We are live on ! Find out more
QCG

Quadrant Capital Group Portfolio holdings

AUM $3.34B
1-Year Est. Return 29.16%
This Fund
S&P 500
This Quarter Est. Return
+4.25%
1 Year Est. Return
+29.16%
3 Year Est. Return
+77.72%
5 Year Est. Return
+92.59%
10 Year Est. Return
+303.92%
AUM
$3.31B
AUM Growth
+$234M
Cap. Flow
+$153M
Cap. Flow %
4.61%
Top 10 Hldgs %
29.6%
Holding
2,810
New
136
Increased
1,119
Reduced
861
Closed
104

Top Sells

Rank Stock Value
1
RDY icon
Dr. Reddy's Laboratories
RDY
+$3.19M
2
HD icon
Home Depot
HD
+$2.88M
3
COOP
Mr. Cooper
COOP
+$2.26M
4
PG icon
Procter & Gamble
PG
+$2.02M
5
CRM icon
Salesforce
CRM
+$1.9M

Sector Composition

Rank Sector Weight
1 Technology 22.8%
2 Financials 12.6%
3 Consumer Discretionary 7.91%
4 Healthcare 7.45%
5 Industrials 7.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LXU icon
2451
LSB Industries
LXU
$830M
$3K ﹤0.01%
+353
New +$3.12K
AVNS icon
2452
Avanos Medical
AVNS
$1.17B
$2.98K ﹤0.01%
265
+77
+41% +$881
CBAN icon
2453
Colony Bankcorp
CBAN
$463M
$2.98K ﹤0.01%
167
NG icon
2454
NovaGold Resources
NG
$2.63B
$2.95K ﹤0.01%
316
WERN icon
2455
Werner Enterprises
WERN
$2.43B
$2.94K ﹤0.01%
98
-1,440
-94% -$39.6K
BOH icon
2456
Bank of Hawaii
BOH
$3.19B
$2.94K ﹤0.01%
43
ARI
2457
Apollo Commercial Real Estate
ARI
$880M
$2.88K ﹤0.01%
298
EPAM icon
2458
EPAM Systems
EPAM
$4.89B
$2.87K ﹤0.01%
14
-34
-71% -$6.06K
MAIN icon
2459
Main Street Capital
MAIN
$5B
$2.84K ﹤0.01%
47
ORN icon
2460
Orion Group Holdings
ORN
$500M
$2.83K ﹤0.01%
+285
New +$2.76K
LE icon
2461
Lands' End
LE
$374M
$2.82K ﹤0.01%
194
+36
+23% +$556
AVXL icon
2462
Anavex Life Sciences
AVXL
$233M
$2.81K ﹤0.01%
790
-1,061
-57% -$6.5K
BFST icon
2463
Business First Bancshares
BFST
$1.02B
$2.8K ﹤0.01%
107
-402
-79% -$10.2K
MLTX icon
2464
MoonLake Immunotherapeutics
MLTX
$1.66B
$2.77K ﹤0.01%
+210
New +$2.48K
EU
2465
enCore Energy
EU
$231M
$2.77K ﹤0.01%
1,115
+471
+73% +$1.35K
AMN icon
2466
AMN Healthcare
AMN
$1.31B
$2.76K ﹤0.01%
175
+121
+224% +$2.16K
OFIX icon
2467
Orthofix Medical
OFIX
$484M
$2.74K ﹤0.01%
181
FET icon
2468
Forum Energy Technologies
FET
$646M
$2.73K ﹤0.01%
+74
New +$2.3K
SXC icon
2469
SunCoke Energy
SXC
$767M
$2.69K ﹤0.01%
374
-134
-26% -$986
RES icon
2470
RPC Inc
RES
$1.22B
$2.68K ﹤0.01%
493
+305
+162% +$1.58K
SLP icon
2471
Simulations Plus
SLP
$371M
$2.68K ﹤0.01%
+147
New +$2.58K
CDZI icon
2472
Cadiz
CDZI
$257M
$2.66K ﹤0.01%
+474
New +$2.54K
JBI icon
2473
Janus International
JBI
$727M
$2.66K ﹤0.01%
406
LAES icon
2474
SEALSQ Corp
LAES
$552M
$2.65K ﹤0.01%
+701
New +$3.57K
WRBY icon
2475
Warby Parker
WRBY
$3.07B
$2.62K ﹤0.01%
120

Similar funds

Quadrant Capital Group's Q4 2025 Portfolio in Review

As of Q4 2025, Quadrant Capital Group held 2,810 positions worth $3.31B, up 7.6% from $3.08B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Quadrant Capital Group deployed $153M of net new capital in Q4 2025, opening 136 new positions and adding to 1,119 existing holdings. Its largest new stake was Capital Group Global Growth Equity ETF: 18,866 shares worth $654K.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Dr. Reddy's Laboratories, an estimated $3.19M trimmed.

  • Quadrant Capital Group's largest Q4 2025 buy was Capital Group Global Growth Equity ETF: 18,866 shares worth $654K.
  • Quadrant Capital Group added most to State Street SPDR S&P 500 ETF Trust in Q4 2025, an estimated $16.7M increase.
  • Quadrant Capital Group's biggest Q4 2025 reduction was Dr. Reddy's Laboratories, cutting an estimated $3.19M.
  • Quadrant Capital Group fully exited Mr. Cooper in Q4 2025, selling an estimated $2.26M.
  • Quadrant Capital Group's ten largest holdings make up 30% of its $3.31B portfolio in Q4 2025.
  • Quadrant Capital Group opened 136 new positions and closed 104 in Q4 2025.
  • Quadrant Capital Group's portfolio value rose 7.6% quarter-over-quarter to $3.31B.

Based on Quadrant Capital Group's 13F filing for Q4 2025, filed 13 Feb 2026.